Skip to content

Released Feb 29, 2012

10-K filed Feb 29, 2012, 60 days after period end · 0001047469-12-001846

Q4 2011 · 10-K
Revenue$32.15M+91.7% vs Q4 2010+163.2% vs Q3 2011
Net Income-$6.97MN/M vs Q4 2010N/M vs Q3 2011
EPS Diluted-$0.07N/M vs Q4 2010N/M vs Q3 2011
Operating Incomederived-$7,032,000—
Operating Cash Flowderived-$7,701,000N/M
Free Cash Flowderived-$11,350,000N/M
Margins · derived
Operating margin-21.9%
Net margin-21.7%+47.8 pt vs Q4 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2011Q4 2010
Revenue$32.15M$16.77M
Net Income-$6.97M-$11.65M
EPS Diluted-$0.07-$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR